Published in:
01-02-2004 | Poster presentation
The use of recombinant factor VIIa as a haemostatic agent in ICU patients
Authors:
P Vernikos, D Xanthis, S Georgiou, N Archontoulis, A Mega, K Rigas, J Pavleas, O Katsarou, G Thomopoulos
Published in:
Critical Care
|
Special Issue 1/2004
Login to get access
Excerpt
Recombinant factor VIIa (rFVIIa) is a prohaemostatic agent that has successfully been used for the treatment of patients with haematological malignancies and coagulopathy. It also has been used in postsurgical patients where the coagulopathy in combination with hypothermia and metabolic acidosis causes an increase of mortality early post operation. Recently reported has been the use of rFVIIa in patients with a normal coagulation system, undergoing major surgery in order to reduce the intraoperative bleeding and the need for transfusions. Here we present our experience on rFVIIa use in ICU patients. …
